GlassScriptPhysician profile
Ahmed Mostafa Eldib
NPI 1144683624
$14,001.45
in general payments reported to CMS, 2019-2025
13 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,462 · 2023: $5,190 · 2024: $5,305 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,776 · Travel and Lodging: $4,578 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,640 · Consulting Fee: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,776.39 |
| Travel and Lodging | $4,577.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,640.00 |
| Consulting Fee | $1,545.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,728.89 | 2022-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $4,308.96 | 2022-2025 | Persona, Avenir, Arcos |
| W. L. Gore & Associates, INC. | $1,640.00 | 2025 | Product In Development |
| Medacta USA, INC. | $1,199.92 | 2023 | Amistem, Gmk Sphere |
| Medical Device Business Services, INC. | $963.73 | 2023-2025 | Na |
| Encore Medical, LP | $320.81 | 2024 | Djo Surgical |
| Depuy Synthes Sales INC. | $222.96 | 2023 | Actis, Na |
| Linkbio Corp | $179.31 | 2023 | |
| Integra Lifesciences Corporation | $172.23 | 2022 | |
| Genzyme Corporation | $153.51 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $70.43 | 2024 | Saphnelo |
| Heron Therapeutics, INC. | $25.67 | 2023 | Zynrelef |
| Next Science LLC | $15.03 | 2023 | Surgx, Blastx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Eldib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.